Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Selective ETA receptor ligands and their use reported by Pfizer scientists

Feb. 23, 2001

Fujisawa discloses inhibitors of NO production

Feb. 23, 2001

Avant reports preliminary results of phase I extension trial for cholesterol management vaccine

Feb. 23, 2001

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

GlaxoSmithKline and Sepsicure establish agreement for sepsis treatment

Feb. 23, 2001

Altace approved in Canada for expanded indication

Feb. 20, 2001

Acute hemodynamic effects and safety of tezosentan in NYHA class III-IV CHF

Feb. 20, 2001

Positive hemodynamic results reported in phase III trial of tezosentan

Feb. 19, 2001

New Aventis compounds block Kv1.5 potassium channels

Feb. 19, 2001

MicroHeart obtains exclusive license to angiogenic/antiinflammatory compound

Feb. 19, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...